Nymox Pharmaceutical Corp (NYMX) - Medical Equipment - Deals and Alliances Profile

Region:Central and South America

Author(s):

Product Code:GDME63111D

Download Sample Report download
Buy the Full ReportStarting from $250
Published on

October 2018

Total pages

68

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $250

About the Report

About the Report

Summary

Nymox Pharmaceutical Corp (Nymox) is a biopharmaceutical company that undertakes the research and development of therapeutics and diagnostics devices to target the unmet needs of the aging population. The company markets diagnostic products for measuring tobacco product exposure and for the diagnosis of Alzheimer's disease. Its diagnostic product portfolio includes NicAlert test to determine smoking status; and TobacAlert home test to determine person's level of exposure to tobacco products, including second hand smoke. Nymox's lead drug candidate, NX-1207 intended for the treatment of BPH (benign prostatic hyperplasia) and certain types of cancer. It has subsidiaries in New Jersey, the US. Nymox is headquartered in Nassau, the Bahamas.

Nymox Pharmaceutical Corp (NYMX)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Products

Products

Nymox Pharmaceutical Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Table of Contents

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 6

Nymox Pharmaceutical Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Nymox Pharmaceutical Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 8

Nymox Pharmaceutical Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Nymox Pharmaceutical Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 10

Nymox Pharmaceutical Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 11

Nymox Pharmaceutical Corp, Medical Equipment, Deal Details 14

Equity Offering 14

Nymox Pharma Raises USD2.24 Million in Private Placement of Shares 14

Nymox Pharmaceutical to Raise USD12 Million in Private Placement 15

Nymox Pharma Raises USD0.35 Million in Private Placement of Shares 16

Nymox Pharma Raises USD0.59 Million in Private Placement of Shares 17

Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 18

Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 19

Nymox Pharma Raises USD0.25 Million in Private Placement of Shares 20

Nymox Pharma Raises USD0.15 Million in Private Placement of Shares 21

Nymox Pharma Raises USD0.15 million in Private Placement of Shares 22

Nymox Pharma Raises USD0.15 Million in Private Placement of Shares 23

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 24

Nymox Pharma Raises USD0.3 million in Private Placement of Shares 25

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 26

Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 27

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 28

Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 29

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 30

Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 31

Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 32

Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 33

Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 34

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 35

Nymox Pharma Raises USD0.3 million in Private Placement of Shares 36

Nymox Pharma Raises USD0.14 Million in Private Placement of Shares 37

Nymox Pharma Raises USD0.15 Million in Public Offering of Shares 38

Nymox Pharma Raises USD0.35 Million in Public Offering of Shares 39

Nymox Pharma Raises USD0.35 Million in Private Placement of Shares 40

Nymox Pharma Raises USD0.35 Million in Private Placement of Shares 41

Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 42

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 43

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 44

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 45

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 46

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 47

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 48

Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 49

Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 50

Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 51

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 52

Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 53

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 54

Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 55

Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 56

Nymox Pharma Raises USD1.1 Million in Private Placement of Shares 57

Nymox Pharma Raises USD1 Million in Private Placement of Shares 58

Nymox Pharma Raises USD1 Million in Private Placement of Shares 59

Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 60

Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 61

Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 62

Nymox Pharma Raises USD1 Million in Private Placement of Shares 63

Nymox Pharmaceutical Corp-Key Competitors 64

Nymox Pharmaceutical Corp-Key Employees 65

Nymox Pharmaceutical Corp-Locations And Subsidiaries 66

Head Office 66

Other Locations & Subsidiaries 66

Recent Developments 67

Other Significant Developments 67

Jul 02, 2018: NYMOX Announces Expanded Marketing Plans 67

Appendix 68

Methodology 68

About GlobalData 68

Contact Us 68

Disclaimer 68


List of Figure

List of Figures

Nymox Pharmaceutical Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Nymox Pharmaceutical Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Nymox Pharmaceutical Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Nymox Pharmaceutical Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Nymox Pharmaceutical Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Nymox Pharmaceutical Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 8

Nymox Pharmaceutical Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Nymox Pharmaceutical Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 10


List of Table

List of Tables

Nymox Pharmaceutical Corp, Medical Equipment, Key Facts, 2017 2

Nymox Pharmaceutical Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Nymox Pharmaceutical Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Nymox Pharmaceutical Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 8

Nymox Pharmaceutical Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Nymox Pharmaceutical Corp, Deals By Market, 2012 to YTD 2018 10

Nymox Pharmaceutical Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 11

Nymox Pharma Raises USD2.24 Million in Private Placement of Shares 14

Nymox Pharmaceutical to Raise USD12 Million in Private Placement 15

Nymox Pharma Raises USD0.35 Million in Private Placement of Shares 16

Nymox Pharma Raises USD0.59 Million in Private Placement of Shares 17

Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 18

Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 19

Nymox Pharma Raises USD0.25 Million in Private Placement of Shares 20

Nymox Pharma Raises USD0.15 Million in Private Placement of Shares 21

Nymox Pharma Raises USD0.15 million in Private Placement of Shares 22

Nymox Pharma Raises USD0.15 Million in Private Placement of Shares 23

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 24

Nymox Pharma Raises USD0.3 million in Private Placement of Shares 25

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 26

Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 27

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 28

Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 29

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 30

Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 31

Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 32

Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 33

Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 34

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 35

Nymox Pharma Raises USD0.3 million in Private Placement of Shares 36

Nymox Pharma Raises USD0.14 Million in Private Placement of Shares 37

Nymox Pharma Raises USD0.15 Million in Public Offering of Shares 38

Nymox Pharma Raises USD0.35 Million in Public Offering of Shares 39

Nymox Pharma Raises USD0.35 Million in Private Placement of Shares 40

Nymox Pharma Raises USD0.35 Million in Private Placement of Shares 41

Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 42

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 43

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 44

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 45

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 46

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 47

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 48

Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 49

Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 50

Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 51

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 52

Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 53

Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 54

Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 55

Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 56

Nymox Pharma Raises USD1.1 Million in Private Placement of Shares 57

Nymox Pharma Raises USD1 Million in Private Placement of Shares 58

Nymox Pharma Raises USD1 Million in Private Placement of Shares 59

Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 60

Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 61

Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 62

Nymox Pharma Raises USD1 Million in Private Placement of Shares 63

Nymox Pharmaceutical Corp, Key Competitors 64

Nymox Pharmaceutical Corp, Key Employees 65

Nymox Pharmaceutical Corp, Subsidiaries 66

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022